Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Maxim Grymonprez

15PUBLICATIONS
7CO-AUTHORS
Epidemiological modellingHaematological tumoursToxicology (incl. clinical toxicology)PharmacogenomicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Sep 10, 2025
Predictors of mortality and hospitalised exacerbations in obstructive airway diseases.

Delphine Vauterin, Frauke Van Vaerenbergh, Maxim Grymonprez

|Oct 14, 2024
Anticoagulant-related bleeding as a sign of underlying tumoural lesions in patients with atrial fibrillation: a nationwide cohort study.

Kristiaan Proesmans, Maxim Grymonprez, Sylvie Rottey

|Nov 06, 2023
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study.

Maxim Grymonprez, Andreas Capiau, Stephane Steurbaut

|Oct 04, 2023
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.

Maxim Grymonprez, Laura Carnoy, Andreas Capiau

|Sep 14, 2023
Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study.

Maxim Grymonprez, Stephane Steurbaut, Andreas Capiau

|Jun 27, 2023
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.

Maxim Grymonprez, Mirko Petrovic, Tine L De Backer

Pageof 3

Frequent Collaborators

6 joint publications

Lies Lahousse

2 joint publications

Andreas Capiau

1 joint publications

Els Mehuys

1 joint publications

Kristiaan Proesmans

1 joint publications

Delphine Vauterin

1 joint publications

Frauke Van Vaerenbergh

1 joint publications

Guy Joos

Frequent Collaborators

6 joint publications

Lies Lahousse

2 joint publications

Andreas Capiau

1 joint publications

Els Mehuys

1 joint publications

Kristiaan Proesmans

Top Related Videos

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on : Oct 18, 2024

1.4K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on : Feb 28, 2012

83.5K
See more related videos

Top Related Videos

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on : Oct 18, 2024

1.4K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on : Feb 28, 2012

83.5K
See more related videos